WASHINGTON — President Donald Trump’s drug commission is drawing new criticism after it missed a second self-imposed deadline.
Twenty senate Democrats, including Senate Minority Leader Chuck Schumer, have written to the acting director of the Office of National Drug Control Policy urging him to “consider important initiatives that could help deliver faster relief to millions of Americans.”
